| Literature DB >> 18039061 |
Jeanne Leventhal Alexander1, Henry Burger, Lorraine Dennerstein, Nancy Fugate Woods, Susan R Davis, Krista Kotz, Julie Van Winkle, Gregg Richardson, Anna Ratka, Bruce Kessel.
Abstract
This article aims to educate the nonpsychiatric as well as the psychiatric clinician on the impact of vasomotor symptoms in women with comorbid psychiatric problems and the challenges of treating vasomotor symptoms in these women. The pathophysiology, prevalence and common risk factors associated with disturbing hot flashes in the menopausal transition are reviewed. Hormonal, nonhormonal and behavioral treatment options of vasomotor symptoms for these women are discussed. Special pharmacokinetic implications for hormonal treatment of those women on anticonvulsant medications for the treatment of their mood disorders, on tamoxifen and/or with high or low sex hormone-binding globulin are examined. An in-depth discussion of mood and the menopausal transition, theoretical mechanisms for mood problems with the symptomatic menopause and the impact of stress on the symptomatic menopause are found elsewhere in this clinical review series on psychiatric illness, stress and the symptomatic menopause.Entities:
Mesh:
Year: 2007 PMID: 18039061 DOI: 10.1586/14737175.7.11s.S115
Source DB: PubMed Journal: Expert Rev Neurother ISSN: 1473-7175 Impact factor: 4.618